A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

A heart attack, or acute myocardial infarction (AMI), occurs when blood flow to the heart is blocked, damaging the heart ...

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

8 月 30 日～9 月 2 日，世界最具影响力的心血管学术会议——2024 年欧洲心脏病学会（ESC）年会于英国伦敦举行，此次 ESC 年会设置了 26 场最新科学研究专场（Late-Breaking Science）共 163 项研究、12 场 ...

A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

By improving triage, an artificial intelligence program could significantly aid emergency departments that are often ...

通常情况下，即使免疫系统处于“开窗期”，也不足以导致人生病。然而，如果在熬夜后进行高强度运动，这无疑就是让已经疲惫不堪的免疫系统雪上加霜，此时细菌、病毒等病原体也就更容易趁虚而入了。

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...

The following is a summary of “Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved ...

JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.